Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence C. Forstner, C. Dungl, S. Tobudic, D. Mitteregger, H. Lagler, H. Burgmann Clinical Microbiology and Infection Volume 19, Issue 7, Pages E291-E297 (July 2013) DOI: 10.1111/1469-0691.12169 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Organogram of the study protocol, 28-day mortality and long-term outcome 1 year after methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Clinical Microbiology and Infection 2013 19, E291-E297DOI: (10.1111/1469-0691.12169) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 2 Cumulative survival curve of patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia with and without pneumonia during the follow-up period of 1 year shows that the survival in the group of patients with pneumonia (n = 17) was worse than in the group of patients without pneumonia (n = 107) (Log rank significance test p 0.023). Clinical Microbiology and Infection 2013 19, E291-E297DOI: (10.1111/1469-0691.12169) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions